Castanares, Arcelita M.
HRN: 21-76-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
CEFTRIAXONE 1G (VIAL)
08/31/2022
09/06/2022
INTRAVENOUS
2 Grams
Q 24 Hours
Empiric - CAP/ PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes